The Flowr Corporation Stock Toronto S.E.
Equities
FLWR.H
CA34354X1087
Pharmaceuticals
Sales 2020 | 7.51 10.28 | Sales 2021 | 12.35 16.9 | Capitalization | 22.37M 30.61M |
---|---|---|---|---|---|
Net income 2020 | -126M -172M | Net income 2021 | -85M -116M | EV / Sales 2020 | 16,546,858 x |
Net Debt 2020 | 29.2M 39.96M | Net Debt 2021 | 17.1M 23.4M | EV / Sales 2021 | 3,196,178 x |
P/E ratio 2020 |
-0.35
x | P/E ratio 2021 |
-0.24
x | Employees | - |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 65.85% |
1st Jan change | Capi. | |
---|---|---|
+43.25% | 6.3B | |
-15.08% | 4.53B | |
-6.70% | 3.29B | |
+5.47% | 3.2B | |
+0.76% | 2.63B | |
+47.75% | 1.97B | |
-5.08% | 1.74B | |
+2.05% | 1.69B | |
-7.08% | 1.64B |